Search - tctmd.com

Displaying 621 - 640 of 2206

Sort: Relevancy | Date

News Industry News

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

July 21, 2015

News Daily News

DES, BMS Both Suitable for Treating Patients With SVG Lesions

July 20, 2015

News Daily News

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Todd Neale

July 16, 2015

News Daily News

Meta-analysis Confirms Safety of PCI without Surgical Backup

July 16, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Industry News

Cardiovascular Systems Completes Coast Study Enrollment

July 14, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Daily News

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

L.A. McKeown

July 13, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Daily News

Extent of Coronary Calcium Predicts Long-term Mortality Risk in Symptom-Free Patients

Todd Neale

July 09, 2015

News Daily News

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

Yael L. Maxwell

July 08, 2015

News Industry News

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

July 08, 2015

News Daily News

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

L.A. McKeown

July 08, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

Advertisement

Minneapolis Heart Institute® Physician Serves as National PI in Research Trial Aiming to Improve Outcomes for Those with Peripheral Arterial Disease

DES, BMS Both Suitable for Treating Patients With SVG Lesions

MVARC Document Offers Template for Mitral Valve Therapeutics Research

Meta-analysis Confirms Safety of PCI without Surgical Backup

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Cardiovascular Systems Completes Coast Study Enrollment

FDA Approves Heart Failure Drug That Comes With Survival Benefit

After Pulmonary Embolism, Benefit of Secondary Anticoagulation Does Not Persist

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Extent of Coronary Calcium Predicts Long-term Mortality Risk in Symptom-Free Patients

Older Age Tied to Higher Risk of Recurrent Cerebral Ischemia in PFO Closure Patients

InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award

Acute MI Arising From Coronary Embolism Rare, Often Tied to A-fib

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

Statement on LAA Closure Highlights Key Issues for Growing Field

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content